Mihalatos M, Apessos A, Papadopoulou E, Agnantis N J, Yannoukakos D, Fountzilas G, Nasioulas G
Molecular Biology Research Center HYGEIA Antonis Papayiannis, Kifissias Ave. & Erythrou Stavrou 4 Str, GR151-23 Maroussi, Athens, Greece.
Anticancer Res. 2003 May-Jun;23(3A):2191-3.
Familial Adenomatous Polyposis (FAP)-a premalignant clinical entity inherited as an autosomal dominant trait-is characterized by the development of hundreds to thousands of adenomatous polyps of the colorectum during the second and third decade of life. Approximately 80% of the FAP patients harbour truncating germ-line mutations in the APC tumor suppressor gene (Adenomatous Polyposis Coli). We tested 48 members from 9 families. Two novel truncating mutations were identified-2601delGA, R923X--and five already known mutations R564X, R876X, Q1045X, 3927-3931delAAAGA and D1822V were found. Our method for testing was PCR amplification from genomic DNA extracted from whole blood, followed by automated DNA sequencing.
家族性腺瘤性息肉病(FAP)——一种作为常染色体显性性状遗传的癌前临床实体——的特征是在生命的第二个和第三个十年期间,结肠直肠会出现数百到数千个腺瘤性息肉。大约80%的FAP患者在APC肿瘤抑制基因(腺瘤性息肉病 coli)中携带截短的种系突变。我们对9个家族的48名成员进行了检测。鉴定出两个新的截短突变——2601delGA,R923X——并发现了五个已知突变R564X、R876X、Q1045X、3927 - 3931delAAAGA和D1822V。我们的检测方法是从全血中提取的基因组DNA进行PCR扩增,然后进行自动DNA测序。